Spyre Therapeutics, Inc.
SYRE
$44.07
$4.1810.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.60% | -7.67% | -6.77% | -6.35% | 45.59% |
| Total Receivables | -54.55% | 88.57% | 2.94% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.57% | 34.89% | 465.37% | -71.26% | 4.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 54.14% | -6.35% | -5.43% | -6.36% | 44.50% |
|
|
|||||
| Total Current Assets | 54.14% | -6.35% | -5.43% | -6.36% | 44.50% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00% | 0.00% |
| Total Assets | 54.14% | -6.35% | -5.43% | -6.36% | 44.50% |
|
|
|||||
| Total Accounts Payable | 19.40% | 100.89% | 0.62% | 453.90% | -87.11% |
| Total Accrued Expenses | 12.34% | 22.72% | -10.24% | -20.79% | 86.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 53.52% | -74.99% | 32.13% | 73.89% | -30.85% |
| Total Other Current Liabilities | 53.52% | -74.99% | 32.13% | 73.89% | -30.85% |
| Total Current Liabilities | 26.82% | -44.29% | 17.52% | 30.74% | -6.05% |
|
|
|||||
| Total Current Liabilities | 26.82% | -44.29% | 17.52% | 30.74% | -6.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.50% | -- | -- | -54.97% | 1.27% |
| Total Liabilities | 26.34% | -40.40% | -4.71% | -3.87% | -3.22% |
|
|
|||||
| Common Stock & APIC | 23.66% | 0.75% | 0.75% | 0.68% | 22.83% |
| Retained Earnings | -5.87% | -1.06% | -3.61% | -4.60% | -6.14% |
| Treasury Stock & Other | 9.86% | 74.23% | -33.43% | 278.89% | -87.65% |
| Total Common Equity | 86.92% | -0.22% | -8.21% | -9.72% | 110.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 86.92% | -0.22% | -8.21% | -9.72% | 110.98% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.16% | -0.15% | -5.56% | -6.80% | 58.16% |
|
|
|||||